IKEA and Kodiak Robotics have a new pilot program. Photo courtesy of Kodiak

A California-based driving trucking company has announced a new partnership with IKEA to pilot autonomous freight deliveries in Texas.

Kodiak Roboticsand IKEA agreed on a pilot program announced today that will transport IKEA products seven days a week between the IKEA Distribution Center in Baytown and the IKEA Store in Frisco.

"We are proud to be working with Kodiak to achieve our ambitious goals of being at the forefront of innovation and building capabilities for future transportation," says Dariusz Mroczek, category area transport manager of IKEA Supply Chain Operations, in a news release. "Kodiak's technology will contribute towards our objective to put the driver in focus in the transition towards automated transportation and towards our road safety agenda."

The pilot program will flesh out Kodiak's technology, and each vehicle will have a professional safety truck driver behind the wheel to oversee the autonomous delivery.

"IKEA and Kodiak share a commitment to putting safety first," sats Don Burnette, founder and CEO of Kodiak Robotics, in the release. "Together we can enhance safety, improve working conditions for drivers, and create a more sustainable freight transportation system. Adopting autonomous trucking technology can improve drivers' quality of life by focusing on the local driving jobs most prefer to do. We look forward to working with the IKEA carrier partners to bring these benefits to the IKEA supply chain."

Founded in 2018, Kodiak has been delivering freight daily in Texas since mid-2019, which includes a Dallas to Houston, adding a Dallas to San Antonio round last year.

"Dallas will be our home base for testing and operations for the foreseeable future," Burnette said in 2019. "Kodiak plans to continue refining and testing its trucks until the last truck-involved accident happens on public roads."

The company picked Texas for its truck tests, in part, because of the "warm welcome" extended by Gov. Greg Abbott, TxDOT, the Texas Department of Public Safety, the Texas A&M Transportation Institute, and other segments of the public sector, Burnette told InnovationMap.

In addition, Burnette says, Kodiak chose Texas "because of its great people, freight-rich economy, reasonable regulatory structure, and robust infrastructure."

The company wants to make Texas "the home of self-driving trucks." Photo courtesy of Kodiak Robotics

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.